Association between remnant cholesterol (RC) and endometriosis: a cross-sectional study based on NHANES data.

Zeru Chen, Ruixuan Li, Jiajie Guo, Xiaorong Ye, Yang Zhou, Mingzhu Cao
Author Information
  1. Zeru Chen: Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  2. Ruixuan Li: Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  3. Jiajie Guo: Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  4. Xiaorong Ye: Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  5. Yang Zhou: Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China. zhouyang2009hi@126.com.
  6. Mingzhu Cao: Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China. 2019683081@gzhmu.edu.cn.

Abstract

BACKGROUND: Prior research indicates a potential link between dyslipidemia and endometriosis (EMs). However, the relationship between remnant cholesterol (RC) and EMs has not been thoroughly investigated. Consequently, looking into and clarifying the connection between RC and EMs was the primary goal of this study.
METHODS: Following the screening of participants from the NHANES dataset spanning 2001 to 2006, a total of 1,840 individuals were incorporated into this research. A weighted multivariable logistic regression analysis was first performed to investigate the relation between RC and the likelihood of encountering EMs. To assess the degree of consistency in the link between RC and EMs across different populations, additional subgroup analyses were performed. In addition, the researchers used the extreme gradient boosting (XGBoost) technique and the area under the receiver operating characteristic curve (ROC) to evaluate how well RC recognized EMs. Lastly, both linear and nonlinear relationships were validated using generalized additive models (GAM), while dose-response connections were investigated through restricted cubic spline models.
RESULTS: After accounting for all potential confounders, a strong correlation between RC and EMs was identified. In particular, an increase of one unit in RC was linked to a 135% rise in the likelihood of developing EMs. Analyses of subgroups revealed that these relationships remained stable across the majority of subgroups (interaction P-value > 0.05). Multivariable logistic regression demonstrated RC's independent predictive value, maintaining statistical significance after adjusting for confounders. The AUC of 0.614 suggests RC's moderate ability to discriminate EMs, outperforming traditional markers like LDL-C in sensitivity and specificity. Furthermore, XGBoost analysis identified RC as the most critical predictor among lipid-related and demographic variables. The relationship was further validated through GAM, which visually confirmed a linear trend, and RCS, which provided statistical evidence of linearity.
CONCLUSION: This study reveals a clear connection between RC and the likelihood of having EMs within the US population, suggesting RC as a potential marker for further investigation in understanding endometriosis risk.

Keywords

References

  1. Circulation. 2013 Sep 17;128(12):1298-309 [PMID: 23926208]
  2. Lancet. 2004 Nov 13-19;364(9447):1789-99 [PMID: 15541453]
  3. Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2133-2135 [PMID: 27784698]
  4. Brain Res. 2017 Jan 1;1654(Pt B):123-144 [PMID: 27590721]
  5. Lipids Health Dis. 2023 Jul 21;22(1):104 [PMID: 37480052]
  6. Nat Rev Endocrinol. 2014 May;10(5):261-75 [PMID: 24366116]
  7. J Immunol Res. 2018 Sep 12;2018:6285813 [PMID: 30276219]
  8. Front Immunol. 2024 Apr 10;15:1352946 [PMID: 38660308]
  9. Cent Eur J Immunol. 2022;47(1):109-116 [PMID: 35600152]
  10. Ann Epidemiol. 2014 Oct;24(10):727-33 [PMID: 25108688]
  11. Am Fam Physician. 2006 Aug 15;74(4):594-600 [PMID: 16939179]
  12. BMC Womens Health. 2024 Jul 4;24(1):387 [PMID: 38965508]
  13. Zentralbl Gynakol. 2002 Dec;124(12):559-65 [PMID: 12822069]
  14. Mymensingh Med J. 2023 Jan;32(1):118-124 [PMID: 36594311]
  15. Eur Heart J Open. 2022 Feb 02;2(1):oeac001 [PMID: 35919664]
  16. Adolesc Health Med Ther. 2013 Jan 18;4:1-21 [PMID: 24600293]
  17. Vital Health Stat 1. 2013 Aug;(56):1-37 [PMID: 25078429]
  18. J Proteome Res. 2016 Aug 5;15(8):2626-33 [PMID: 27246581]
  19. BMC Public Health. 2024 Mar 8;24(1):743 [PMID: 38459526]
  20. Lipids Health Dis. 2024 Jun 8;23(1):176 [PMID: 38851714]
  21. Front Immunol. 2023 Jul 11;14:1225639 [PMID: 37497226]
  22. Eur Heart J. 2021 Nov 7;42(42):4324-4332 [PMID: 34293083]
  23. Arch Gynecol Obstet. 2023 Jan;307(1):59-69 [PMID: 35377041]
  24. Front Endocrinol (Lausanne). 2024 May 28;15:1371393 [PMID: 38863936]
  25. Fertil Steril. 2007 Nov;88(5):1285-7 [PMID: 17991515]
  26. Hypertens Res. 2024 May;47(5):1157-1166 [PMID: 38212367]
  27. Circ Cardiovasc Imaging. 2021 Apr;14(4):e010953 [PMID: 33832329]
  28. Hum Reprod. 2023 Sep 5;38(9):1835-1842 [PMID: 37487110]
  29. Reprod Biomed Online. 2021 Aug;43(2):319-328 [PMID: 34103260]
  30. Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1714-1721 [PMID: 28939588]
  31. Lipids Health Dis. 2024 Apr 24;23(1):121 [PMID: 38659020]
  32. Eur Heart J. 2010 Jan;31(2):222-6 [PMID: 19687163]
  33. Reprod Biol Endocrinol. 2022 Dec 21;20(1):174 [PMID: 36544197]
  34. J Clin Endocrinol Metab. 2018 Jan 1;103(1):64-74 [PMID: 29040578]
  35. Nat Rev Immunol. 2015 Feb;15(2):104-16 [PMID: 25614320]
  36. Int J Mol Sci. 2023 Feb 21;24(5): [PMID: 36901685]
  37. Lipids Health Dis. 2024 Feb 22;23(1):55 [PMID: 38388371]
  38. BMC Womens Health. 2024 Jun 1;24(1):316 [PMID: 38824532]
  39. Lipids Health Dis. 2024 Feb 7;23(1):38 [PMID: 38326904]
  40. Contraception. 2005 Feb;71(2):111-7 [PMID: 15707560]
  41. Maturitas. 2024 Aug;186:107970 [PMID: 38580554]
  42. Rom J Morphol Embryol. 2023 Jul-Sep;64(3):343-354 [PMID: 37867352]
  43. BMC Public Health. 2024 Feb 5;24(1):373 [PMID: 38317119]
  44. Front Endocrinol (Lausanne). 2023 Dec 13;14:1324429 [PMID: 38192421]
  45. J Obstet Gynaecol Res. 2014 Feb;40(2):479-84 [PMID: 24124978]
  46. Lipids Health Dis. 2024 May 18;23(1):148 [PMID: 38762471]
  47. Reprod Fertil. 2021 May 06;2(2):R35-R50 [PMID: 35128453]
  48. Sci Rep. 2023 Dec 4;13(1):21388 [PMID: 38049434]
  49. Clin Exp Reprod Med. 2017 Mar;44(1):28-32 [PMID: 28428941]
  50. Reprod Biomed Online. 2024 Jul;49(1):103856 [PMID: 38657291]
  51. Hum Reprod. 2018 Apr 1;33(4):715-727 [PMID: 29401293]
  52. Obstet Gynecol Clin North Am. 1987 Mar;14(1):107-19 [PMID: 3306515]
  53. Lipids Health Dis. 2022 Nov 14;21(1):120 [PMID: 36376895]
  54. Hum Fertil (Camb). 2022 Oct;25(4):745-753 [PMID: 33926361]
  55. Arch Gynecol Obstet. 2023 Jan;307(1):221-222 [PMID: 35192038]
  56. Int J Mol Sci. 2019 Aug 05;20(15): [PMID: 31387263]
  57. Front Endocrinol (Lausanne). 2022 Apr 25;13:852671 [PMID: 35546998]
  58. Eur J Pharmacol. 2024 Feb 5;964:176261 [PMID: 38141938]
  59. Sci Rep. 2023 Oct 31;13(1):18708 [PMID: 37907559]
  60. Int Immunopharmacol. 2011 Oct;11(10):1442-50 [PMID: 21586343]
  61. PLoS One. 2024 May 31;19(5):e0301752 [PMID: 38820493]

Grants

  1. KTPYJ 2023014/Xinjiang Support Rural Science and Technology (SpecialCorrespondent) Program in Guangdong Province

MeSH Term

Humans
Female
Endometriosis
Adult
Cholesterol
Cross-Sectional Studies
Nutrition Surveys
Middle Aged
ROC Curve
Logistic Models
Triglycerides

Chemicals

Cholesterol
Triglycerides

Word Cloud

Created with Highcharts 10.0.0RCEMsstudypotentialcholesterolNHANESlikelihoodresearchlinkendometriosisrelationshipremnantinvestigatedconnectionlogisticregressionanalysisperformedacrossgradientboostingXGBoostoperatingcharacteristiccurvelinearrelationshipsvalidatedadditivemodelsGAMconfoundersidentifiedsubgroupsRC'sstatisticalBACKGROUND:PriorindicatesdyslipidemiaHoweverthoroughlyConsequentlylookingclarifyingprimarygoalMETHODS:Followingscreeningparticipantsdatasetspanning20012006total1840individualsincorporatedweightedmultivariablefirstinvestigaterelationencounteringassessdegreeconsistencydifferentpopulationsadditionalsubgroupanalysesadditionresearchersusedextremetechniqueareareceiverROCevaluatewellrecognizedLastlynonlinearusinggeneralizeddose-responseconnectionsrestrictedcubicsplineRESULTS:accountingstrongcorrelationparticularincreaseoneunitlinked135%risedevelopingAnalysesrevealedremainedstablemajorityinteractionP-value > 005MultivariabledemonstratedindependentpredictivevaluemaintainingsignificanceadjustingAUC0614suggestsmoderateabilitydiscriminateoutperformingtraditionalmarkerslikeLDL-CsensitivityspecificityFurthermorecriticalpredictoramonglipid-relateddemographicvariablesvisuallyconfirmedtrendRCSprovidedevidencelinearityCONCLUSION:revealsclearwithinUSpopulationsuggestingmarkerinvestigationunderstandingriskAssociationendometriosis:cross-sectionalbaseddataCross-sectionalEndometriosisExtremeGeneralizedmodelReceiverRemnant

Similar Articles

Cited By